Subjects Undergoing Antiretroviral Innate Immune Effectors in HIV-1-Infected Determine the Extent of Reconstitution of Baseline Viral Load and Immune Activation

[1]  M. Lederman,et al.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. , 2007, Blood.

[2]  J. Herbeuval,et al.  HIV-1 immunopathogenesis: how good interferon turns bad. , 2007, Clinical immunology.

[3]  L. Montaner,et al.  Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells , 2007, AIDS.

[4]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[5]  R. Dummer,et al.  Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells , 2006, The Journal of Immunology.

[6]  F. Hecht,et al.  Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment , 2006, AIDS.

[7]  M. Lederman,et al.  Interferon-α differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection , 2006 .

[8]  M. Kruhlak,et al.  Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Akira,et al.  Toll-like receptor function and signaling. , 2006, The Journal of allergy and clinical immunology.

[10]  Zhengfan Jiang,et al.  Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. , 2006, Annual review of immunology.

[11]  R. Lempicki,et al.  Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions12 , 2006, The Journal of Immunology.

[12]  A. Fauci,et al.  NK cells in HIV infection: Paradigm for protection or targets for ambush , 2005, Nature Reviews Immunology.

[13]  M. Müller-Trutwin,et al.  Role for plasmacytoid dendritic cells in anti‐HIV innate immunity , 2005, Immunology and cell biology.

[14]  A. Moretta.  The dialogue between human natural killer cells and dendritic cells. , 2005, Current opinion in immunology.

[15]  Andrea Scozzafava,et al.  Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. , 2005, Current pharmaceutical design.

[16]  L. Montaner,et al.  Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children. , 2005, The Journal of infectious diseases.

[17]  J. Lifson,et al.  TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. , 2005, Blood.

[18]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Trinchieri,et al.  The Reciprocal Interaction of NK Cells with Plasmacytoid or Myeloid Dendritic Cells Profoundly Affects Innate Resistance Functions1 , 2005, The Journal of Immunology.

[20]  M. Desvarieux,et al.  Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection. , 2004, The Journal of infectious diseases.

[21]  R. Steinman,et al.  Dendritic Cell Numbers in the Blood of HIV-1 Infected Patients Before and After Changes in Antiretroviral Therapy , 2004, Journal of Clinical Immunology.

[22]  Jessica M Malenfant,et al.  Increased Natural Killer Cell Activity in Viremic HIV-1 Infection1 , 2004, The Journal of Immunology.

[23]  T. Chun,et al.  Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Daucher,et al.  Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Caroline A Sabin,et al.  The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy , 2003, AIDS.

[26]  A. Moretta.  Natural killer cells and dendritic cells: rendezvous in abused tissues , 2002, Nature Reviews Immunology.

[27]  F. Schildberg,et al.  Induction of cytotoxicity against autologous tumour cells by interleukin-12:evidence for intrinsic anti-tumor immune capacity in curatively resected gastrointestinal tumour patients , 2002, Cancer Immunology, Immunotherapy.

[28]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[29]  G. Trinchieri,et al.  Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals1 , 2002, The Journal of Immunology.

[30]  G. Trinchieri,et al.  Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells , 2002, The Journal of experimental medicine.

[31]  Giovanni Melioli,et al.  Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.

[32]  P. Fitzgerald-Bocarsly,et al.  Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection. , 2001, AIDS.

[33]  F. Gheyas,et al.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.

[34]  J. Margolick,et al.  Increase and Plateau of CD4 T‐Cell Counts in the 3½ Years After Initiation of Potent Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.

[35]  E. Rosenberg,et al.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Pantaleo,et al.  Immunopathogenesis of HIV infection. , 1998, AIDS research and human retroviruses.

[37]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[38]  I. Frank,et al.  IL-15 enhances immune functions during HIV infection. , 1997, Journal of immunology.

[39]  J V Giorgi,et al.  Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[40]  G. Trinchieri,et al.  Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cells , 1993, European journal of immunology.

[41]  I. Frank,et al.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients , 1992, The Journal of experimental medicine.

[42]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[43]  G. Trinchieri,et al.  Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood. , 1989, Immunology.

[44]  F. Siegal,et al.  DEFICIENCY OF INTERFERON‐ALPHA GENERATING CAPACITY IS ASSOCIATED WITH SUSCEPTIBILITY TO OPPORTUNISTIC INFECTIONS IN PATIENTS WITH AIDS a , 1984, Annals of the New York Academy of Sciences.

[45]  G. Poli,et al.  Dendritic cells and natural killer cells in the pathogenesis of HIV infection , 2005, Immunologic research.

[46]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[47]  G. Trinchieri,et al.  Production of type I interferons: plasmacytoid dendritic cells and beyond , 2005 .

[48]  F. Siegal.  Interferon-producing plasmacytoid dendritic cells and the pathogenesis of AIDS. , 2003, Research initiative, treatment action : RITA.

[49]  J. Levy.  HIV and host immune responses in AIDS pathogenesis , 1993, Journal of clinical apheresis.